Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actelion

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Actelion's 2013 sales performance.

Deal Watch January 2018

In comparison, this time last year January's top 20 deals represented $52bn in aggregate headline value (buoyed by J&J's $30bn acquisition of Actelion).  The aggregate value of the

Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ French pharma firm offers $105 apiece for the spin-out’s shares. After missing out on earlier bids for Medivation and Actelion, Sanofi has agreed to buy Biogen haematology spin-out ... Medivation in 2016 and was also trumped by Johnson &Johnson after

After some big setbacks, Sanofi talks up its R&D portfolio

After some big setbacks, Sanofi talks up its R&D portfolio However, it has tried and failed to make two pipeline-boosting acquisitions of late, losing out out to rivals bidding for Actelion and Medivation.

J&J files would-be prostate cancer blockbuster in US

J&J files would-be prostate cancer blockbuster in US They also suggest that J&J’s recent acquisition of Actelion will help sales growth accelerate.

Biosimilars eat into J&J's Remicade sales

Biosimilars eat into J&J's Remicade sales This is the first set of financial results for J&J since it closed the acquisition of Swiss biotech Actelion, a specialist in pulmonary arterial hypertension (PAH), on June 16.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Keep your audiences close
How getting up close and personal with target audiences can fuel creativity...
The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....

Infographics